AKT1 and cancer: The AKT pathway serves as a central signaling axis, and its dysregulation has been associated with various conditions, including developmental and overgrowth syndromes, cancer, cardiovascular diseases, insulin resistance, type 2 diabetes, inflammatory and autoimmune disorders, as well as neurological diseases such as alzheimer’s, parkinson’s, and stroke.